Editorial on the Occasion of the 20th Anniversary of Endocrine Metabolic Immune Disorders-Drug Targets Journal with a Kaleidoscopic Vision of Selected Publications.
Endocrinology
drug targeting
immunology
metabolism
nutrition
therapy
Journal
Endocrine, metabolic & immune disorders drug targets
ISSN: 2212-3873
Titre abrégé: Endocr Metab Immune Disord Drug Targets
Pays: United Arab Emirates
ID NLM: 101269157
Informations de publication
Date de publication:
2020
2020
Historique:
received:
28
07
2020
revised:
01
08
2020
accepted:
01
08
2020
pubmed:
9
10
2020
medline:
30
9
2021
entrez:
8
10
2020
Statut:
ppublish
Résumé
Over the past 20 years, Endocrine Metabolic Immune Disorders-Drug Targets (EMIDDT) journal has been covering a broad field of intertwined topics related to pathogenesis, diagnosis, and therapy of endocrine, metabolic, and immune diseases. At first, the journal publications were restricted to reviews only and, then, original article submissions have also been accepted. EMIDDT represents as a successful journal in continuous expansion with 10 issues in 2020 and a current impact factor (IF) equal to 1.973. Moreover, since 2019, EMIDDT is the official journal of the Italian AME (Associazione Medici Endocrinologi), also linked to the American Association of Endocrinologists. Such a connection has given more impetus to the journal in terms of additional higher-quality submissions. In order to celebrate the 20th anniversary of EMIDDT, the content of some original representative articles published by the journal in the past and current years will be illustrated with special emphasis on cellular and molecular bases of drug targeting.
Identifiants
pubmed: 33030139
pii: EMIDDT-EPUB-110530
doi: 10.2174/1871530320666201007152628
doi:
Types de publication
Editorial
Historical Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1696-1710Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.